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Objective: To compare the osteoporosis awareness and its association with 10-year fracture risks be-
tween young and old breast cancer survivors.
Methods: During the 2011 Pink October campaign hosted by the Taiwan Breast Cancer Alliance and the
Taiwanese Osteoporosis Association, questionnaires on osteoporosis awareness and FRAX variables were
distributed. Data from participants aged 40 years and older (n ¼ 807) were analyzed. Comparisons were
made between those aged below and above 50 years, and among different tertiles of predicted fracture
risk groups.
Results: Mean age was 56.0 ± 7.7 years. Only half (52.7%) showed a high level of osteoporosis awareness.
Older survivors were more likely to exhibit higher awareness levels (55.0% vs. 44.8%; p < 0.05). Moreover,
osteoporosis awareness increased among higher predicted 10-year major osteoporosis fracture risk
groups. Older survivors (age  50 years) also had a higher body mass index, higher prevalence of sec-
ondary osteoporosis, and higher predicted 10-year fracture risk (p < 0.05).
Conclusion: Osteoporosis awareness levels were higher among older and higher fracture risk breast
cancer survivors. Educational program and osteoporosis prevention strategies may start with younger
and lower fracture risk breast cancer survivors to increase the awareness in order to reduce under-
management of osteoporosis.
Copyright © 2016, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Breast cancer is the most common cancer among women
worldwide. Advances in both cytotoxic chemotherapy and endo-
crine therapy have reduced breast cancer mortality1. However,
chemoendocrine therapy has some negative effects on bone health,
including increased risk of fracture2,3. Although effective treatment
and prevention methods of osteoporosis exist, under-detection andre that they have no conﬂicts
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es/by-nc-nd/4.0/).under-treatment are common in the general population and breast
cancer patients4. Poor awareness and knowledge of osteoporosis
may be one of the reason for under-management of osteoporosis5.
Past studies have shown relatively low levels of osteoporosis
awareness within the general population6e10. However, studies on
osteoporosis awareness among breast cancer patients are limited.
The association of osteoporosis awareness between younger and
older population was inconclusive in the previous studies6e11.
One previous study showed that people with a previous osteo-
porotic fracture had a better awareness about the osteoporosis11. In
the same study, the awareness was not associated with the severity
of osteoporosis. It is worthwhile to evaluate the association be-
tween osteoporosis awareness and the severity of fracture risks in
order to establish effective educational program to increase
awareness and prevent under-treatment. To the best of ouricine. Published by Elsevier Taiwan LLC. This is an open access article under the CC
C.-J. Wen et al.34knowledge, no study has yet evaluated osteoporosis awareness and
its association with fracture risks among breast cancer survivors.
Besides, there is no standard guideline to deﬁne high fracture risks
patients in breast cancer survivors12.
To advance the research on osteoporosis awareness, the objec-
tives of this study are twofold: (1) to evaluate the difference of
osteoporosis awareness between female breast cancer survivors
before and after menopause age participating in a large educational
campaign; and (2) to explore the relationship between osteopo-
rosis awareness and levels of predicted fracture risk groups by
applying the Fracture Risk Assessment Tool (FRAX) algorithm13.
2. Methods
2.1. Participants
The 2011 Pink October campaign was held on October 30 in
Taipei City Hall Plaza. The campaign was sponsored by the Merck,
Sharp & Dohme (MSD) pharmaceutical company, Taiwan, and
designed by the Taiwanese Osteoporosis Association (TOA) and the
Taiwan Breast Cancer Alliance (TBCA). In brief, the purpose of the
annual Pink October campaign is to increase awareness about
ﬁghting and preventing breast cancer. The 2011 event theme was
“Osteoporosis awareness and prevention among breast cancer
survivors.” More than 1000 female breast cancer survivors atten-
ded the event, and 942 anonymously completed and returned the
study questionnaires. Of these, 807 aged 40 years and older (the
lower age limit for FRAX application) were included in the ﬁnal
analysis.
2.2. Measurements
We designed a self-reported questionnaire with three major
components. The ﬁrst part included three osteoporosis awareness
questions. Question 1: Do you know that the mortality rate of
osteoporosis is similar to that of stage 4 breast cancer? Question 2:
Do you know that breast cancer treatment accelerates bone loss?
Question 3: Do you know that 41% of Taiwanese women older than
50 years have osteoporosis? We deﬁned the level of osteoporosis
awareness by number of correct answers to the three proposed
questions. We created an awareness level index by assigning a
1-point value to a “yes” answer for each question. A score  2
indicated a high level of awareness on osteoporosis. The three
questions developed by experts were designed to ﬁnd out that if
participants know important concept of osteoporosis and its
association to breast cancer. Therefore, those who knew more
correct answers to the questions were considered to have higher
osteoporosis awareness in this population. The second part of the
questionnaire (Question 4) involved the plan that the participants
would implement if they knew they were at high risk for osteo-
porosis or fractures. The potential plans included the following: (1)
visiting a physician; (2) other: please specify. The last section of the
questionnaire involved the 11 variables required for FRAX use
including age, sex, weight, height, previous fracture, hip fracture
history of parents, smoking status, steroid use, rheumatoid arthritis
history, secondary osteoporosis history, and current alcohol intake.
Body mass index (BMI) was calculated as weight (kg) divided by
height squared (m2). Instructions were given before participants
ﬁlling the questionnaire by the trained volunteers from the TBCA.
They also helped the participants ﬁll out the questionnaires when
necessary. The TOA acquired data from MSD in order to perform
data analysis independently. Because our noninterventional study
was carried out in public and the information was collected
anonymously, without personal identiﬁers, informed consent was
not needed. We also applied for a certiﬁcate of exempt review fromthe international review board in National Taiwan University
Hospital. Prediction of the 10-year major osteoporotic fracture and
hip fracture risk by FRAX was derived from the Taiwanese calcu-
lator. The high risk cutoff points were deﬁned as a 10-year major
osteoporotic fracture probability  20% or hip fracture risk proba-
bility  3%, as suggested by Taiwanese Osteoporosis Clinical
Treatment Guidelines14.
2.3. Statistical analyses
The participants were further divided into two groups, using age
50 years (a proxy for menopausal status) as the cutoff point. Stu-
dent t test was used to compare themean values of the younger and
older participants. Percentages and categorical variables were
tested with the c2 test and Fisher exact test where appropriate. We
divided the predicted fracture risks into tertiles. Logistic regression
model with adjustment for age and trend test were applied to
explore the relationship between the tertiles of fracture risks and
osteoporosis awareness derived from three questions. Further, the
association between age groups (divided into groups by decades)
and fracture risk was plotted. All statistical analyses were per-
formed using SAS statistical software, version 9.1 (SAS Institute,
Inc., Cary, NC, USA).
3. Results
Baseline characteristics of participants are shown in Table 1. The
mean agewas 56.0± 7.7 years. The ﬁrst, second, and third questions
on osteoporosis awareness were answered “yes” by 30.7%, 68.9%,
and 56.3% of participants, respectively. Nearly 92% of participants
stated that they would visit a physician if they were at high-risk for
fracture. The proportion of older survivors exhibiting a high
awareness level about osteoporosis was greater than that of
younger survivors (55.0% vs. 44.8%; p < 0.05). Risk factors that were
present in  10% of the participants included previous fracture,
parent hip fracture, glucocorticoid use, and secondary osteoporosis.
According to the FRAX model, 19.6% (hip fracture risk) and 5.8%
(major osteoporotic fracture) of the participants were considered at
high-risk for fracture. Compared to younger survivors
(age < 50 years), older survivors were also shorter, and had higher
BMI and secondary osteoporosis prevalence (all p < 0.05).
The relationship between osteoporosis awareness level and the
severity of 10-year major osteoporotic fracture risk probability
(divided into tertiles) is presented in Table 2. Except for Question 3,
statistically signiﬁcant trends of increased osteoporosis awareness
among participants at higher risk for major osteoporotic fracture
were found after adjusting for age. For instance, compared to the
low-risk group, participants in the middle- and high-risk groups
were 1.76 (1.14e2.70) and 2.20 (1.29e3.75) times more likely to
answer “yes” to Question 1, respectively. Similar trend between
osteoporosis awareness and tertile of predicted 10-year hip fracture
risk was found. However, the trend was not statistically signiﬁcant
(data not shown).
Figure 1 shows the distribution of mean 10-year major osteo-
porotic fracture risk and hip fracture risk probabilities with age. We
found a steadily increased mean fracture risk for each decade from
age 40 years, until it reached a plateau at age 80 years.
4. Discussion
In the present study, we found a consistently low level of oste-
oporosis awareness among breast cancer survivors, with higher
levels of awareness observed among older participants. Osteopo-
rosis awareness increased in the groups with higher predicted 10-
year major osteoporotic fracture risk by FRAX. In general, the
Table 1
FRAX variables and osteoporosis awareness levels among Taiwanese female breast cancer survivors (n ¼ 807).
Total (807, 100%) < 50 years (181, 22.4%)  50 years (626, 77.6%)
Question 1: answered yes, n (%) 248 (30.7) 45 (24.9) 203 (32.4)
Question 2: answered yes, n (%) 556 (68.9) 121 (66.9) 435 (69.5)
Question 3: answered yes, n (%) 454 (56.3) 86 (47.5)** 368 (58.8)
High awareness level (score  2), n (%) 425 (52.7) 81 (44.8)* 344 (55.0)
Question 4: answered yesc, n (%) 744 (92.2) 172 (95.0) 572 (91.4)
Weight (kg), mean (SD) 58.3 (8.5) 57.9 (8.8) 58.4 (8.4)
Height (cm), mean (SD) 157.3 (5.1) 158.7 (5.0)*** 156.9 (5.0)
Body mass index (kg/m2), mean (SD) 23.6 (3.4) 23.0 (3.7)* 23.7 (3.3)
Previous fracture, n (%) 124 (15.4) 21 (11.6) 103 (16.5)
Parent hip fracture, n (%) 105 (13.1) 18 (9.9) 87 (13.9)
Current smoking, n (%) 16 (2.0) 2 (1.1) 14 (2.2)
Glucocorticoids, n (%) 88 (10.9) 25 (13.8) 63 (10.1)
Rheumatoid arthritis, n (%) 69 (8.6) 13 (7.2) 56 (9.0)
Secondary osteoporosis, n (%) 109 (13.5) 15 (8.3)* 94 (15.0)
Three or more alcohol units/d, n (%) 13 (1.6) 3 (1.7) 10 (1.6)
Predicted 10-year hip fracture risk 3%, n (%) 158 (19.6) 4 (2.2)*** 154 (24.6)
Predicted 10-year major osteoporosis fracture risk 20%, n (%) 47 (5.8) 2 (1.1)** 45 (7.2)
For full details of questions, see Methods section. *: p < 0.05, **: p< 0.01, ***: p< 0.001.
SD ¼ standard deviation.
Table 2
Distribution of osteoporosis awareness levels across the tertiles of major osteoporotic fracture risk.
Predicted 10-year major osteoporotic fracture risk p
Low-risks
0e3.8 (%)
Middle-risks
3.8e7.5 (%)
High-risks
7.5e9.4 (%)
Question 1: answered yes, n (%) 67 (25.2) 86 (32.8) 95 (34.1)
OR 1 1.76 (1.14e2.70) 2.20 (1.29e3.75) 0.005
Question 2: answered yes, n (%) 167 (62.8) 199 (76.0) 190 (68.1)
OR 1 2.29 (1.48e3.54) 1.85 (1.08e3.16) 0.032
Question 3: answered yes, n (%) 140 (52.6) 142 (54.2) 172 (61.7)
OR 1 1.02 (0.69e1.51) 1.33 (0.81e2.19) 0.255
High awareness level, n (%) 125 (47.0) 143 (54.6) 157 (56.3)
OR 1 1.51 (1.02e2.24) 1.78 (1.09e2.94) 0.024
OR ¼ odds ratio (Model adjusted for age).
Figure 1. The association between different age groups (by decade) and fracture risks.
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risk increase steadily for each decade from age 40 years to 80 years.
In a study conducted in Korea7, osteoporosis awareness was
assessed using the following question: “Have you been diagnosed
with osteoporosis?” and only 37.5% of osteoporotic women
answered “yes” to the question. In a Turkish study8, all participants
were asked if they had information or thoughts on osteoporosis,
and roughly half (54%) of the osteoporotic women had some
knowledge about osteoporosis. In China11, only 30.7% of a com-
munity population had heard of osteoporosis and 18.5% of themhad heard of osteoporotic fracture. Roughly half of our study par-
ticipants (52.7%) were considered to have a high level of awareness,
deﬁned by answered “yes” in two of the three questions. Although
the study populations and questions used to deﬁne osteoporosis
awareness were different, we found that osteoporosis awareness
was consistently low7,8,11. However, in contrast with the Turkish8
and Korean studies10, we found a positive association between
older age and osteoporosis awareness. One possible explanation is
that younger breast cancer survivors mainly focus on their cancer
treatment, while older survivors who lived longer, may have higher
chance to be exposed to information on osteoporosis. The primary
prevention strategies of osteoporosis may focus on the younger
ages to improve the low awareness situation.
Xu et al11 found that people with a history of a previous oste-
oporotic fracture had better awareness than those without such a
history in a community population study. However, the awareness
was not associated with the severity of osteoporosis measured by
quantitative ultrasound at the calcaneus. In our study, we demon-
strated a positive association between osteoporosis awareness and
the 10-year major osteoporotic fracture risk predicted by FRAX.
Therefore, strategies to increase the osteoporosis awareness among
breast cancer survivors may need to be tailored to different risk
groups for more effective delivery of information.
Over 90% of our participants stated that they would visit a
physician if they were at high-risk for osteoporosis or fracture. A
previous study showed that misunderstanding use of glucosamine
supplements to treat osteoporosis group has higher fracture risks
than those without misunderstanding use, which also implies that
C.-J. Wen et al.36low knowledge and awareness of osteoporosis may have higher
fracture risks15. Another previous study had also shown that raising
awareness about osteoporosis might increase the rate of detection
and treatment5. Given the cross-sectional nature of the study, we
could not identify the exact percentage of high-risk patients who
did actually seek medical care after receiving information from the
campaign. However, improvements in osteoporosis detection may
be achieved if a signiﬁcant number of high-risk participants would
visit healthcare providers as they expressed in their questionnaire
statements.
It is well known that the risk of fracture increases with age in
general population. Leslie et al found that, among Canadian
community-dwelling women, the 10-year major osteoporotic
fracture risk probability increased from 5.3% at age 50 years to 21%
at age 85 years. Moreover, the 10-year hip fracture risk increased
from 1.8% at age 50 years to 7.2% at age 85 years16. Our study re-
ported similar trends but higher fracture risk percentages for each
age group among breast cancer survivors. Comparisons should be
made with caution since our study reported the fracture risk esti-
mates among a convenient sample of Asian breast cancer survivors.
However, the observed high predicted fracture risk suggests the
need for increasing attention to and awareness of osteoporosis
prevention and treatment among breast cancer survivors.
Although our study provided important epidemiological infor-
mation on osteoporosis awareness among breast cancer survivors
in Asia, it also has some limitations. First, we only have the face
validity of our osteoporosis awareness questions and did not
perform the reliability test. Besides, we deﬁned a score 2 as a high
level of awareness on osteoporosis, which was from posthoc anal-
ysis, not a prespeciﬁed cutoff point. Therefore, the observed asso-
ciation between osteoporosis awareness and fracture risks should
be interpreted with caution. Second, our study population was
selected from volunteers who attended the campaign, rather than
from a nationally representative sample. Individuals who attend
health promotion events are probably healthier and having better
osteoporosis awareness than breast cancer patients in general.
Third, theWorld Health Organization FRAX algorithmwas designed
for the general population and may not be completely applicable to
breast cancer survivors. Other guidelines suggest different sets of
clinical risk factors that use information speciﬁc to breast cancer
survivors17e19. We had no detailed cancer-related participant data
that we could incorporate into a cancer-speciﬁc osteoporotic frac-
ture prediction model. However, the percentage of participants in
our study that required treatment, based on FRAX predictions, was
similar to that identiﬁed by other disease-speciﬁc protocols20.
Fourth, although instructions were given before administration of
questionnaires, participantsmight still misunderstand themeaning
of secondary osteoporosis, which may overestimate the fracture
risks. Fifth, the height and weight included in the FRAX were self-
reported not measured, which may have nondirectional bias and
underestimate the fracture risks.
In summary, from a large-scale breast cancer survivors' educa-
tional campaign, older participants had higher levels of osteopo-
rosis awareness and higher predicted fracture risks than younger
participants. The level of osteoporosis awareness among partici-
pants was consistently low, but it was better among higher fracturerisk groups. Therefore, educational program and osteoporosis
prevention strategies may start with younger and lower facture risk
breast cancer survivors to increase the awareness in order to reduce
under-management of osteoporosis.
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